Article metrics

Download PDFPDF

First-line treatment for patients with advanced non-small cell lung carcinoma and high PD-L1 expression: pembrolizumab or pembrolizumab plus chemotherapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to March 2024

AbstractFullPdf
Dec 2019220
Jan 2020991
Feb 202020206
Mar 2020303023
Apr 202031315
May 202041417
Jun 2020474710
Jul 2020383814
Aug 2020393928
Sep 2020656542
Oct 2020474732
Nov 2020414128
Dec 2020282810
Jan 2021373718
Feb 2021393927
Mar 2021696935
Apr 2021484832
May 2021343425
Jun 2021525230
Jul 2021303020
Aug 2021666637
Sep 2021595932
Oct 2021999959
Nov 2021808043
Dec 2021596134
Jan 2022404216
Feb 2022333323
Mar 2022464630
Apr 2022283022
May 2022434628
Jun 2022313417
Jul 2022353616
Aug 2022363713
Sep 2022313219
Oct 2022141615
Nov 2022262619
Dec 202221218
Jan 2023323217
Feb 2023464629
Mar 2023353621
Apr 2023252620
May 2023373721
Jun 2023282816
Jul 2023383831
Aug 2023343519
Sep 202325258
Oct 2023454514
Nov 2023444416
Dec 2023656527
Jan 2024343517
Feb 2024494912
Mar 2024373714
Total206820891106